San Carlos, Calif. — May 14, 2019 — MarkLogic Corporation, the next generation data platform provider for simplifying data integration, today announced the MarkLogic® Pharma Research Hub to enable pharmaceutical companies to lower drug trial costs and accelerate research. This is achieved by helping researchers quickly and easily find, synthesize and share high-quality data—including, genetic, proteomic, drug, textual, binary and clinical trial data—within a single cloud service.
The MarkLogic Pharma Research Hub uses machine learning and other advanced technologies including semantics, fuzzy matching, relevance ranking and rich metadata to manage, organize and retrieve information. As a fully managed cloud service, the Pharma Research Hub can be set up in minutes and ingests data 10x faster than custom-developed solutions—with zero IT management burden.
“Researchers using legacy technology only access slivers of the data around them, increasing the likelihood of errors and costing valuable time that can equate to hundreds of millions of lost dollars and, more importantly, lost opportunities to change lives because drugs take so long to develop,” said Bill Fox, Vice President of Vertical Strategy Group and Chief Strategy Officer of Healthcare and Life Sciences at MarkLogic. “We offer researchers a cloud-based service to easily bring together massive amounts of data, in its original form, and understand the relationships between all that data, so they can use that data to discover life-changing drugs faster.”
By working with five of the largest global pharmaceutical companies and other leaders in the healthcare ecosystem, MarkLogic has long used its Data Hub technology to help solve pharmaceutical companies’ business and data challenges by:
“Due to advances in technology that solve many data analytics challenges while also meeting the stringent regulatory requirements of the health industry, we expect substantial data management solution adoption in life science research R&D,” said Alan Louie, Life Sciences Research Director at IDC. “This new breed of industry-centric technology promises significant near-term value while also creating new best practices that will drive the industry forward for decades to come.”
The Pharma Research Hub standardizes and extends the best practices from multiple customers. The underlying MarkLogic Data Hub Platform has been used to run some of the most complex businesses for nearly two decades. The platform is built for Petabytes but can also be cost-effectively scoped to small data sets. It is governed and secure from the beginning unlike data stored in a Hadoop® data lake, which can take years to build while the business waits for results.
More information on the MarkLogic Pharma Research Hub is available here.
MarkLogic helps customers create value from complex data faster. Our platform ingests data from any source, creating and refining metadata to support powerful models. Customers use these models for deep search and query, building enterprise applications and bringing unique insights to analytics and machine learning.
Vector Capital is a San Francisco-based leading global private equity firm focused on transformative investments in technology and technology-enabled businesses. Founded in 1997, Vector oversees approximately $4 billion of capital across its private equity and credit strategies from a variety of investors including university endowments, foundations, and financial institutions. With our disciplined approach to valuation and deep-rooted operational experience, Vector has generated competitive returns and established a successful track record spanning nearly 25 years. For more information, please visit www.vectorcapital.com.